edistride
astrazeneca ab - dapagliflozin propāndiols monohidrāts - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - cukura diabēts - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. papildus citām zālēm, lai ārstētu 2. tipa cukura diabētu. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 un 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.
forxiga
astrazeneca ab - dapagliflozin propāndiols monohidrāts - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - cukura diabēts - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. papildus citām zālēm, lai ārstētu 2. tipa cukura diabētu. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 un 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.
zynquista
guidehouse germany gmbh - sotagliflozin - cukura diabēts, 1. tipa - cukura diabēts - zynquista ir norādīts kā palīglīdzekli, lai insulīna terapiju, lai uzlabotu glycaemic kontroles pieaugušajiem ar 1. tipa cukura diabētu ar Ķermeņa masas indekss (Ķmi) ≥ 27 kg/m2, kas ir izdevies, lai panāktu pietiekamu glycaemic kontroles neskatoties optimāli insulīna terapija.
remens pilieni iekšķīgai lietošanai, šķīdums
richard bittner ag, austria - cimicifuga racemosa, katru dienu, kanādas, pilocarpus, sepia officinalis, lachesis - pilieni iekšķīgai lietošanai, šķīdums
flavamed 30 mg/5 ml šķīdums iekšķīgai lietošanai
berlin-chemie ag, germany - ambroksola hidrohlorīds - Šķīdums iekšķīgai lietošanai - 30 mg/5 ml
mirtastad 30 mg apvalkotās tabletes
stada arzneimittel ag, germany - mirtazapīns - apvalkotā tablete - 30 mg
mirtastad 15 mg apvalkotās tabletes
stada arzneimittel ag, germany - mirtazapīns - apvalkotā tablete - 15 mg
metronidazole b.braun 5 mg/ml šķīdums infūzijām
b.braun melsungen ag, germany - metronidazols - Šķīdums infūzijām - 5 mg/ml
yasminelle 0,02 mg/3 mg apvalkotās tabletes
bayer ag, germany - ethinylestradiolum, drospirenonum - apvalkotā tablete - 0,02 mg/3 mg
flavamed 60 mg putojošās tabletes
berlin-chemie ag (menarini group), germany - ambroksola hidrohlorīds - putojošā tablete - 60 mg